Abstracts - faqs.org

Abstracts

Science and technology

Search abstracts:
Abstracts » Science and technology

In Singapore, a company with ambitious goals leads a "privileged existence"

Article Abstract:

Singapore-based Embryonic Stem Cell International (ESI) has emerged as one of world's first commercial ventures to focus on developing stem cells for therapeutic purposes. Considering the financial support given by the Singapore government that holds a 44 percent stake in ESI, it has a privileged existence.

Author: Burton, John
Publisher: Scientific American, Inc.
Publication Name: Scientific American
Subject: Science and technology
ISSN: 0036-8733
Year: 2005
Government domestic functions, Singapore, Science and technology policy

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


The former patent powerhouse works on new therapies

Article Abstract:

California-based Geron Company was founded in 1992 as one of the first public companies to study embryonic stem cells. Geron is pursuing research in a wide number of disease areas, including Parkinson's, heart disease, diabetes, arthritis, blood disease, osteoporosis, and organ transplantation.

Author: Griffith, Victoria
Publisher: Scientific American, Inc.
Publication Name: Scientific American
Subject: Science and technology
ISSN: 0036-8733
Year: 2005
Strategy & planning, Planning, Company business planning, Geron Corp., GERN

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


The tiny company that ignited a political battle over human therapeutic cloning continues to punch above its weight

Article Abstract:

Advanced Cell Technology (ACT) announced in the year 2001 that it had cloned a short-lived human embryo, igniting a political battle in the US Congress. Despite the controversy and excitement surrounding its science, the company has always maintained its dignity and reputation.

Author: Griffith, Victoria
Publisher: Scientific American, Inc.
Publication Name: Scientific American
Subject: Science and technology
ISSN: 0036-8733
Year: 2005
Advanced Cell Technology Inc.

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Management, Product development, Biotechnology industry, Biotechnology industries, Finance, Embryology, Experimental, Embryological research, Company business management, Company financing, Stem cell research, United States
Similar abstracts:
  • Abstracts: String revival: Are cosmic strings behind unusual lensing effects?. Rare flare: odd magnetar burst partly solves gamma-ray riddle
  • Abstracts: The California gambit. Positive public attitudes lift British scientists above destructive fray
  • Abstracts: Wading in Waste: Thanks to unchecked development along America's coasts, disease-causing microbes are increasingly fouling beaches and shellfish beds.
  • Abstracts: The ghost of Lysenko. Worse than gasoline: Liquid coal would produce toughly twice the global warming emissions of gasoline
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.